In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
about
STX140, but not paclitaxel, inhibits mammary tumour initiation and progression in C3(1)/SV40 T/t-antigen transgenic miceAntiangiogenic activity of 2-deoxy-D-glucose.In vivo and in vitro properties of STX2484: a novel non-steroidal anti-cancer compound active in taxane-resistant breast cancer.Major histocompatibility complex-I expression on embryonic stem cell-derived vascular progenitor cells is critical for syngeneic transplant survival.Ultrastructural changes of erythrocytes in whole blood after exposure to prospective in silico-designed anticancer agents: a qualitative case studyInduction of the intrinsic apoptotic pathway via a new antimitotic agent in an esophageal carcinoma cell lineIn vitro effects of 2-methoxyestradiol-bis-sulphamate on reactive oxygen species and possible apoptosis induction in a breast adenocarcinoma cell line.Targeted NF1 cancer therapeutics with multiple modes of action: small molecule hormone-like agents resembling the natural anticancer metabolite, 2-methoxyoestradiol.The In Vitro and In Vivo Activity of the Microtubule Disruptor STX140 Is Mediated by Hif-1 Alpha and CAIX ExpressionThe therapeutic potential of a series of orally bioavailable anti-angiogenic microtubule disruptors as therapy for hormone-independent prostate and breast cancers.The use of steroid sulfatase inhibitors as a novel therapeutic strategy against hormone-dependent endometrial cancer.An overview of tubulin inhibitors that interact with the colchicine binding siteThe in vivo properties of STX243: a potent angiogenesis inhibitor in breast cancer.2-Methoxyoestradiol-3,17-O,O-bis-sulphamate and 2-deoxy-D-glucose in combination: a potential treatment for breast and prostate cancer.BCRP expression does not result in resistance to STX140 in vivo, despite the increased expression of BCRP in A2780 cells in vitro after long-term STX140 exposure.Effects of 2-methoxyestradiol on apoptosis and HIF-1α and HIF-2α expression in lung cancer cells under normoxia and hypoxia.2-Methoxyestradiol-bis-sulphamate refrains from inducing apoptosis and autophagy in a non-tumorigenic breast cell lineThe in vitro effects of a novel estradiol analog on cell proliferation and morphology in human epithelial cervical carcinoma.
P2860
Q28536340-C4146421-A44B-4757-9275-8C473EC3F71EQ33742196-0BC57B5F-91DB-4B2B-B342-3380089931CAQ33918055-B3B03304-5BD5-427C-952C-BBE2A1A6CCE1Q34184100-45626FAA-9035-469E-893E-784311D118E6Q34204897-4B70E1D9-BFB8-4585-B93E-49D8E4E3C8DBQ35563305-27F57152-4656-477D-835B-2F5105F4E0B1Q35652480-8F1664F8-8438-462A-9B61-722007E33435Q35804635-C8024491-C52E-40AD-8CE7-5A808FCA0BFCQ36134768-7478AC4E-D19A-4154-A747-0A6743C17D82Q36610771-559D62B9-F1D3-4227-A4B8-0816608E021DQ36796680-85122780-17B0-482D-ABF0-11F060A590AEQ36885540-0AC15C39-D7F2-4C78-8A53-05B55322ED62Q36964976-5FF7584E-ABE9-4B64-859F-A8463EA68372Q37010557-C3266952-1FFB-480C-9290-56D8377A5890Q37135243-A84CD6A1-AA10-48D6-B491-EA6766E095EAQ38821162-4B46D13F-C895-441A-ADF8-324FC58C8C67Q39294617-848E0345-396F-4A06-BADD-CDB5DD3E003DQ51732181-588249C0-F6EE-4FCE-A94D-B1ADECE298CB
P2860
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
@ast
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
@en
type
label
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
@ast
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
@en
prefLabel
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
@ast
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
@en
P2093
P2860
P356
P1476
In vivo inhibition of angiogenesis by sulphamoylated derivatives of 2-methoxyoestradiol.
@en
P2093
B V L Potter
S K Chander
S P Newman
P2860
P2888
P304
P356
10.1038/SJ.BJC.6603727
P407
P50
P577
2007-04-10T00:00:00Z